AUPH

AURINIA PHARMACEUTICALS INC

AUPH·05156V102·US·Common Stock·Healthcare - Biotechnology-Activist

AUPH (AURINIA PHARMACEUTICALS INC) is held by 150 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($139M), GOLDMAN SACHS GROUP INC ($95.4M), TWO SIGMA INVESTMENTS, LP ($58.8M). Net institutional sentiment: Mixed.

150
Holders
(8 Elite)
$904.6M
Total Value
56% (147)
Consensus
82 buying - 65 selling
13F: Insider & Congress: Updated regularly
AUPH

Smart Money Verdict

View all
Loading verdict
Held by 150 funds
8 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Aug 25, 2026 · Activists Aug 26, 2026 · Congress none

ActivistISILJIN SNT Co., Ltd.3.7%Aug 26, 2026
InsiderRPRobertson Stephen P.Sell $356KAug 21, 2026
ActivistTATANG CAPITAL MANAGEMENT, LLC10.0%Jun 4, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
8.2M(+4.4%)$139M0.0%+67.31%
32
Increased
5.6M(+292.0%)$95.4M0.0%+5.43%
48
Increased
3.5M(+1.1%)$58.8M0.0%+25.66%
30
Decreased
3.3M(-0.6%)$55.4M0.0%+59.32%
0
Increased
2.6M(+2.5%)$43.9M0.0%+83.94%
30
Increased
2.3M(+3.4%)$39.2M0.0%+94.94%
30
Increased
2M(+9.0%)$34.7M0.0%+36.82%
32
Increased
1.7M(+10.8%)$28.9M0.0%+57.87%
32
Decreased
1.5M(-7.0%)$26.3M0.0%+74.18%
0
Decreased
1.4M(-10.5%)$23.9M0.0%+30.95%
0
Increased
1.4M(+8.2%)$23.1M0.0%+15.16%
31
Increased
1.2M(+12.2%)$20.9M0.1%+60.44%
32
Increased
1.1M(+36.2%)$18.6M0.1%+48.87%
37
Increased
978,602(+1.0%)$16.6M0.0%+14.07%
28
Decreased
948,751(-0.0%)$16.1M0.0%+35.06%
0
Increased
863,567(+4.8%)$14.7M0.0%+45.59%
29
Increased
812,915(+24.4%)$13.8M0.0%+23.43%
34
Decreased
596,618(-3.0%)$10.1M0.0%+84.27%
0
Decreased
582,345(-1.4%)$9.9M0.0%+18.49%
0
Increased
567,492(+37.1%)$9.6M0.0%+11.67%
36

Showing 1-20 of 159

1 / 8
AUPHAUPHAURINIA PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used